Hepatitis C Virus (HCV) was found as the causative agent of the Non-A, Non-B Hepatitis (NANBH) in 1989.
Patients infected with the hepatitis C virus (HCV) can present with all the symptoms of acute phase; however, up to half of these patients will progress onto chronic hepatitis.
Hepatitis C has been considered to be the most commonly emerging viral Hepatitis worldwide with major universal devastating consequences.
Hepatitis C Virus (HCV) is a major cause of worldwide morbidity and mortality.
Hepatitis C virus (HCV), a positive sense, single-stranded RNA virus of the Flaviviridae family, is a significant cause of acute hepatitis that displays considerable propensity for progressing to chronic hepatitis.
Infection with Hepatitis C Virus (HCV) results in chronic infection in the majority of infected individuals.
Strong and sustained T-cell responses are essential for HCV clearance.
Until 2011, there was a standstill in the development of new, more efficient therapies for hepatitis C virus (HCV).
As a major world health problem, Hepatitis C Virus (HCV) infection causes various liver diseases.